Judy

Medtronic was named to TIME’s 2026 TIME100 Companies list because its Hugo robotic-assisted surgery platform and Touch Surgery ecosystem are helping expand minimally invasive care, digital surgical intelligence, and global OR innovation. The recognition reflects market leadership in health innovation, strong surgical ecosystem strategy, and a long-term commitment to better outcomes across specialties, including gynecology. […]

In 2026, over 20 U.S. states mandate surgical smoke evacuation systems in operating rooms to protect staff from toxic plumes generated by electrosurgery and lasers, with more global pushes for “Smoke-Free ORs.” Integrated systems syncing evacuators with generators like ForceTriad and RapidVac™ lead compliance, driving market growth. For Sale COVIDIEN Valleylab force Triad Electrosurgical Unit

After years of semiconductor shortages and raw‑material volatility, the global supply chain for electrosurgical generators has stabilized in Q1 2026. This normalization is boosting the availability of high‑end, refurbished units in the secondary market, making premium platforms like the ForceTriad more accessible to emerging‑market hospitals and smaller surgical centers at competitive prices. For Sale COVIDIEN

Smart surgical energy in February 2026 focuses on AI-driven tissue sensing and haptic feedback, with TissueFect™ technology scanning 4,300 times per second for real-time impedance adjustments, setting the industry benchmark as robotics companies like Haply emulate its precision in energy platforms. For Sale COVIDIEN Valleylab force Triad Electrosurgical Unit – HHG Secure Medical Equipment Marketplace

Olympus received FDA 510(k) clearance on April 28, 2026, for the POWERSEAL™ Open Extended Jaw Sealer/Divider, a bipolar device for open surgery. It seals vessels up to 7mm, reduces tissue sticking, and enhances ergonomics, competing directly with Medtronic’s LigaSure™ on ForceTriad systems. Full availability starts late Spring 2026. For Sale COVIDIEN Valleylab force Triad Electrosurgical

The global electrosurgical devices market is projected to grow significantly through 2026, with Ambulatory Surgical Centers (ASCs) capturing the largest market share in many regions. This surge is fueled by the shift toward minimally invasive surgery and the adoption of integrated energy platforms that consolidate multiple technologies into a single, cost‑efficient unit. Devices such as the ForceTriad energy platform are becoming central

Boston Scientific’s strategic acquisition of Nalu Medical, expected to finalize in the first half of 2026, represents a significant consolidation within the neurostimulation sector. This move bolsters Boston Scientific’s chronic pain portfolio by integrating Nalu’s miniaturized peripheral nerve stimulation technology, intensifying competition and distinguishing advanced, long-term implantable solutions from the established, indispensable acute care tools

By mid-2026, medical device manufacturers like B. Braun have stabilized supply chains after semiconductor shortages, ensuring precision instruments such as the Stimuplex HNS 12—with its SENSe technology—meet global demand without backlogs. This recovery supports hospitals in standardizing regional anesthesia equipment across departments, boosting patient care reliability. For Sale B BRAUN 4892098,4163214P Certofix Nerve Stimulator –

The Continuous Peripheral Nerve Block (CPNB) market is set to surge past $680 million in 2026, reaching over $1 billion by 2033 with a 6.2% CAGR, driven by opioid-free pain management demand in orthopedic surgeries like knee and shoulder replacements. Certofix catheters remain essential for precise placement. For Sale B BRAUN 4892098,4163214P Certofix Nerve Stimulator

Dual-guidance protocols, combining real-time ultrasound imaging with nerve stimulation, are establishing a new benchmark for safety in ambulatory surgery centers (ASCs). By integrating physiological confirmation with visual navigation, practitioners can effectively minimize the risk of intraneural injections. As complex procedures migrate to outpatient settings, this combined approach ensures that hospital-grade safety standards remain achievable in